OTCM

OTC Markets Group Inc.

 
Class A Common Stock Alternative Reporting
OTCQX U.S. Premier
 

OTC Disclosure & News Service

 

OTC Markets Group Congratulates Cynapsus Therapeutics on NASDAQ Listing

Jun 18, 2015

OTC Disclosure & News Service

- OTC Markets Group Congratulates Cynapsus Therapeutics on NASDAQ Listing

OTC Markets Group Congratulates Cynapsus Therapeutics on NASDAQ Listing

Canada NewsWire

NEW YORK, June 18, 2015 /CNW/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities, congratulates Cynapsus Therapeutics Inc. on its NASDAQ listing.  Cynapsus, a Toronto-based specialty pharmaceutical company, was previously cross-traded on the OTCQX® Best Marketplace in the U.S.  

Since it joined OTCQX on July 18, 2013, Cynapsus' share price has risen 124% and its global average daily dollar volume has increased substantially. 

"We are thrilled with Cynapsus' success on OTCQX and are pleased to congratulate the company and its management on its offering and NASDAQ listing," said Jason Paltrowitz, Executive Vice President – Corporate Services at OTC Markets Group.  "Our OTCQX and OTCQB premium marketplaces provide convenient U.S. secondary trading markets for Canadian companies like Cynapsus to connect with more investors and grow their businesses.  We wish the company continued success as it takes this next step in its evolution."

"OTCQX helped us expand our investor base and increase our average daily trading volume, which was instrumental in enabling us to qualify for a NASDAQ Global listing," said Anthony Giovinazzo, CEO, President and Director of Cynapsus Therapeutics.

OTC Markets Group is the global leader in exchange graduates, advancing 83 companies to the New York Stock Exchange, NASDAQ and NYSE MKT in 2014.  More than 400 additional companies have graduated from OTC Markets Group's marketplaces in the past four years.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to inform investors of opportunities and risks: the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and the OTC Pink® Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Media Contact:
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otc-markets-group-congratulates-cynapsus-therapeutics-on-nasdaq-listing-300101673.html

SOURCE OTC Markets Group Inc.

Copyright © 2015 PR Newswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.